This Chinese Herb Stock Is Now Bigger Than Super Micro And Reddit

Regencell Bioscience Holdings Ltd. RGC, a Hong Kong-based biotech startup with no reported revenue, has gained more than 59,000% in 2025. The company, which claims to be developing traditional Chinese herbal treatments for childhood ADHD and autism, saw its market value reach nearly $30 billion, by Monday's close. Following a 38-for-1 stock split announced earlier in June, the stock skyrocketed by over 280% on Monday.Read Next: Sunrun, First Solar Plunge—Solar Stocks Hit Hard By Trump Tax Bill: Latest Regen ...